Trial intelligence / Profile preview

Cannabis and Opioid Use Disorder, Study 2

NCT07661446Phase 1Not yet recruiting

Sponsor
University of Kentucky
Start
Nov 2026
Primary completion
Jul 2029
Countries
1
01

Overview

Phase 1 trial of cannabis in opioid use disorder (OUD) (2 arms), sponsored by University of Kentucky. Primary endpoint: Opioid withdrawal severity at 6 hours. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

cannabis
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT07661446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07661446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call